메뉴 건너뛰기




Volumn 24, Issue 7, 2015, Pages 1597-1605

Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation

(76)  Neri, Luca a   Conway, Paul Maurice b   Basilisco, Guido c   Altomare, Donato Francesco d   Annese, Vito e   Badiali, Danilo f   Bassotti, Gabrio g   Battaglia, Edda h   Bazzocchi, Gabriele i   Bellini, Massimo j   Bendia, Emanuele k   Benini, Luigi l   Biscaglia, Giuseppe m   Biviano, Ivano f   Bocchini, Renato n   Bonfrate, Leonilde o   Bonventre, Sebastiano p   Bossa, Fabrizio m   Brandimarte, Giovanni q   Cannizzaro, Renato r   more..


Author keywords

Chronic constipation; Chronic non organic constipation; Constipation severity; Quality of life

Indexed keywords

ADULT; CHRONIC DISEASE; CONSTIPATION; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; UTILIZATION;

EID: 84933278688     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0886-2     Document Type: Article
Times cited : (38)

References (26)
  • 1
    • 70649083242 scopus 로고    scopus 로고
    • Psychometric evaluation of patientreported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation report
    • Spiegel, B., Camilleri, M., Bolus, R., Andresen, V., Chey, W. D., Fehnel, S., et al. (2009). Psychometric evaluation of patientreported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation report. Gastroenterology, 137(6), 1944–1953.
    • (2009) Gastroenterology , vol.137 , Issue.6 , pp. 1944-1953
    • Spiegel, B.1    Camilleri, M.2    Bolus, R.3    Andresen, V.4    Chey, W.D.5    Fehnel, S.6
  • 4
    • 44349130441 scopus 로고    scopus 로고
    • A placebocontrolled trial of prucalopride for severe chronic constipation
    • Camilleri, M., Kerstens, R., Rykx, A., et al. (2008). A placebocontrolled trial of prucalopride for severe chronic constipation. New England Journal of Medicine, 358, 2344–2354.
    • (2008) New England Journal of Medicine , vol.358 , pp. 2344-2354
    • Camilleri, M.1    Kerstens, R.2    Rykx, A.3
  • 5
    • 58149084950 scopus 로고    scopus 로고
    • Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation— A 12-week, randomized, double-blind, placebo-controlled study
    • Quigley, E. M., Vandeplassche, L., Kerstens, R., & Ausma, J. (2009). Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation— A 12-week, randomized, double-blind, placebo-controlled study. Alimentary Pharmacology and Therapeutics, 29, 315–328.
    • (2009) Alimentary Pharmacology and Therapeutics , vol.29 , pp. 315-328
    • Quigley, E.M.1    Vandeplassche, L.2    Kerstens, R.3    Ausma, J.4
  • 6
    • 61649119045 scopus 로고    scopus 로고
    • Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
    • Tack, J., van Outryve, M., Beyens, G., Kerstens, R., & Vandeplassche, L. (2009). Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut, 58, 357–365.
    • (2009) Gut , vol.58 , pp. 357-365
    • Tack, J.1    van Outryve, M.2    Beyens, G.3    Kerstens, R.4    Vandeplassche, L.5
  • 7
    • 32844474925 scopus 로고    scopus 로고
    • Validation of the PAC-SYM questionnaire for opioidinduced constipation in patients with chronic low back pain
    • Slappendel, R., Simpson, K., Dubois, D., & Keininger, D. L. (2006). Validation of the PAC-SYM questionnaire for opioidinduced constipation in patients with chronic low back pain. European Journal of Pain, 10(3), 209–217.
    • (2006) European Journal of Pain , vol.10 , Issue.3 , pp. 209-217
    • Slappendel, R.1    Simpson, K.2    Dubois, D.3    Keininger, D.L.4
  • 10
    • 77957826668 scopus 로고    scopus 로고
    • Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome
    • Wong, R. K., Palsson, O. S., Turner, M. J., et al. (2010). Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. American Journal of Gastroenterology, 105, 2228–2234.
    • (2010) American Journal of Gastroenterology , vol.105 , pp. 2228-2234
    • Wong, R.K.1    Palsson, O.S.2    Turner, M.J.3
  • 11
    • 85000155078 scopus 로고    scopus 로고
    • Questionario sullo stato di salute SF-12, versione italiana. Milan: Guerini e Associati Editore
    • Apolone, G., Mosconi, P., & Quattrocchi, L. (2005). Questionario sullo stato di salute SF-12, versione italiana. Milan: Guerini e Associati Editore. ISBN 8883352017.
    • (2005) ISBN
    • Apolone, G.1    Mosconi, P.2    Quattrocchi, L.3
  • 12
    • 30944453467 scopus 로고    scopus 로고
    • Hierarchical construct validity of the treatment satisfaction questionnaire for medication TSQM version II among outpatient pharmacy consumers
    • Atkinson, M. J., Kumar, R., Cappelleri, J. C., et al. (2005). Hierarchical construct validity of the treatment satisfaction questionnaire for medication TSQM version II among outpatient pharmacy consumers. Value Health, 8(Suppl 1), S9–S24.
    • (2005) Value Health , vol.8 , pp. S9-S24
    • Atkinson, M.J.1    Kumar, R.2    Cappelleri, J.C.3
  • 13
    • 70349742604 scopus 로고    scopus 로고
    • Global rating of change scales: A review of strengths and weaknesses and considerations for design
    • Kamper, S. J., Maher, C. G., & Mackay, G. (2009). Global rating of change scales: A review of strengths and weaknesses and considerations for design. The Journal of Manual and Manipulative Therapy, 17(3), 163–170.
    • (2009) The Journal of Manual and Manipulative Therapy , vol.17 , Issue.3 , pp. 163-170
    • Kamper, S.J.1    Maher, C.G.2    Mackay, G.3
  • 14
    • 33747177642 scopus 로고    scopus 로고
    • A comparison of bifactor and second-order models of quality of life
    • Chen, F., West, S. G., & Sousa, K. H. (2006). A comparison of bifactor and second-order models of quality of life. Multivariate Behavioral Research, 41(2), 189–225.
    • (2006) Multivariate Behavioral Research , vol.41 , Issue.2 , pp. 189-225
    • Chen, F.1    West, S.G.2    Sousa, K.H.3
  • 15
    • 67650706330 scopus 로고    scopus 로고
    • Cut-off criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives
    • Hu, L.-T., & Bentler, P. M. (1999). Cut-off criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.
    • (1999) Structural Equation Modeling , vol.6 , pp. 1-55
    • Hu, L.-T.1    Bentler, P.M.2
  • 16
    • 0037567512 scopus 로고    scopus 로고
    • Defining clinically meaningful change in health-related quality of life
    • Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56, 395–407.
    • (2003) Journal of Clinical Epidemiology , vol.56 , pp. 395-407
    • Crosby, R.D.1    Kolotkin, R.L.2    Williams, G.R.3
  • 17
    • 0032956065 scopus 로고    scopus 로고
    • Determining clinically important differences in health status measures: A general approach with illustration to the health utilities index mark II
    • Samsa, G., Edelman, D., Rothman, M. L., et al. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the health utilities index mark II. Pharmacoeconomics, 15, 141–155.
    • (1999) Pharmacoeconomics , vol.15 , pp. 141-155
    • Samsa, G.1    Edelman, D.2    Rothman, M.L.3
  • 18
    • 0037980149 scopus 로고    scopus 로고
    • Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation
    • Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41, 582–592.
    • (2003) Medical Care , vol.41 , pp. 582-592
    • Norman, G.R.1    Sloan, J.A.2    Wyrwich, K.W.3
  • 19
    • 0038656486 scopus 로고    scopus 로고
    • Simple as possible? Or too simple? Possible limits to the universality of the one-half standard deviation (comment)
    • Beaton, D. E. (2003). Simple as possible? Or too simple? Possible limits to the universality of the one-half standard deviation (comment). Medical Care, 41, 593–596.
    • (2003) Medical Care , vol.41 , pp. 593-596
    • Beaton, D.E.1
  • 20
    • 20144373620 scopus 로고    scopus 로고
    • Another look at the half standard deviation estimate of the minimally important difference in health-related quality of life scores
    • Farivar, S. S., Kiu, H., & Hays, R. D. (2004). Another look at the half standard deviation estimate of the minimally important difference in health-related quality of life scores. Expert Review of Pharmacoeconomics and Outcomes Research, 4(5), 521–529.
    • (2004) Expert Review of Pharmacoeconomics and Outcomes Research , vol.4 , Issue.5 , pp. 521-529
    • Farivar, S.S.1    Kiu, H.2    Hays, R.D.3
  • 21
    • 0036964529 scopus 로고    scopus 로고
    • Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales
    • Cella, D., Eton, D. T., Lai, J., Peterman, A. H., & Merkel, D. E. (2002). Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. Journal of Pain and Symptom Management, 24, 547–561.
    • (2002) Journal of Pain and Symptom Management , vol.24 , pp. 547-561
    • Cella, D.1    Eton, D.T.2    Lai, J.3    Peterman, A.H.4    Merkel, D.E.5
  • 22
    • 83255166685 scopus 로고    scopus 로고
    • Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
    • Maringwa, J. T., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.
    • (2011) Supportive Care in Cancer , vol.19 , Issue.11 , pp. 1753-1760
    • Maringwa, J.T.1    Quinten, C.2    King, M.3    Ringash, J.4    Osoba, D.5    Coens, C.6
  • 25
    • 0030068709 scopus 로고
    • An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation
    • Ashraf, W., Park, F., Lof, J., & Quigley, E. M. M. (1966). An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. American Journal of Gastroenterology, 91(1), 26–32.
    • (1966) American Journal of Gastroenterology , vol.91 , Issue.1 , pp. 26-32
    • Ashraf, W.1    Park, F.2    Lof, J.3    Quigley, E.M.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.